Goldenwell Biotech appoints Ming Zhou to board of directors
GWLL•Goldenwell Biotech appointed Ming Zhou to its board on Oct. 8, 2026, expanding it to four directors. CEO Shuang Liu gifted Zhou 20 million common shares, about 20.2% of outstanding shares.
1. Board appointment
Goldenwell Biotech appointed Ming Zhou to its board on Oct. 8, 2026, expanding the board to four directors. Zhou has been managing director since 2021 at Thailand-based Get Health and Get Intertrading, which focus on health products and distribution. CEO Shuang Liu gifted Zhou 20 million common shares, equal to about 20.2% of outstanding shares.
